Melasma and IPL — Why Barrier Protection Matters More Than Energy Settings
The clinical case for post-IPL barrier support and recombinant collagen in melasma management
The overlooked factor in melasma treatment
The right energy settings matter. But what happens to the skin barrier after IPL — and how you manage it — often determines whether melasma improves or rebounds.
REVAGI The Recombinant Serum supports post-IPL barrier recovery and helps moderate the inflammatory response that triggers melasma rebound — used at licensed aesthetic clinics in Singapore.
Why Melasma Responds Differently to Laser and IPL
Melasma is a chronic pigmentation disorder driven by melanocyte dysregulation — triggered by UV exposure, hormonal factors, and inflammation. Unlike discrete sun spots or freckles, melasma involves a widespread increase in melanocyte activity that persists even when the visible pigmentation is treated.
IPL and laser treatments can effectively clear surface pigmentation — but if the underlying triggers (UV exposure, inflammation) are not controlled, rebound is common. The post-procedure inflammatory response itself can re-trigger the melanocytes that the treatment just suppressed.
Taylor SC, J Am Acad Dermatol, 2002. Ge Y et al., Lasers Med Sci, 2019.
The Barrier Protection Principle
When IPL disrupts the skin surface, the barrier is temporarily compromised. This increases:
- UV penetration to the melanocyte layer — the primary driver of pigmentation relapse
- Environmental irritant penetration — which triggers inflammatory cytokines that stimulate melanocytes
- TEWL — causing dryness and secondary inflammation
Restoring barrier function quickly after IPL is not just about comfort. It is a direct melasma-prevention measure. A product that forms a biomimetic surface layer — like recombinant collagen — provides structural barrier support while the skin heals.
Anti-Inflammatory Support in Melasma Recovery
Recombinant collagen has demonstrated anti-inflammatory properties — moderating the post-procedure inflammatory response without suppressing the healing cascade entirely. For melasma patients, this inflammatory modulation is particularly significant: reduced post-IPL inflammation means reduced melanocyte stimulation, which means lower rebound risk.
Liu TS et al., Regen Biomater. 2024.
The Post-IPL Protocol for Melasma Patients
- From Day 1: apply recombinant collagen serum — anti-inflammatory support, barrier layer formation
- Day 2 onwards: SPF 50+ PA++++ every morning — the most important single measure
- Avoid UV 10am–3pm for at least 4 weeks post-treatment
- No AHAs or BHAs for minimum 10–14 days — inflammatory triggers on sensitised skin
- Continue recombinant collagen serum through the remodelling phase — the melanocyte-stabilising effect is sustained
See also: preventing melasma rebound with recombinant collagen, recombinant collagen in melasma skincare, reducing hyperpigmentation risk post-procedure, and pico laser Singapore guide.
Post-IPL melasma recovery
REVAGI The Recombinant Serum
Anti-inflammatory modulation · Barrier protection · licensed clinics
No retinoids · No AHAs/BHAs · No fragrance · Cosmetic serum